SCHEMBL20127489

SCHEMBL20127489

c1ccc2c(c1)oc1ccc3cc(-c4c5ccccc5c(-c5ccc(-c6ccc7c8ccccc8c8ccccc8c7c6)cc5)c5ccccc45)ccc3c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PLA2G2A P14555 4/20 0.39
PLA2G4A P47712 4/20 0.39
HCRTR1 O43613 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
PGR P06401 1/20 0.37
PLA2G10 O15496 1/20 0.35
GPR84 Q9NQS5 1/20 0.35
ABCG2 Q9UNQ0 3/20 0.34
AHR P35869 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127476 0.96 TDP1 (0.43) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127496 0.94 KDM4E (0.41) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127495 0.93 PLA2G2A (0.42) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL22062818 0.92 ESR1 (0.46) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20412618 0.92 ESR1 (0.42) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127307 0.90 TDP1 (0.41) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127505 0.90 PGR (0.44) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127342 0.90 TDP1 (0.43) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127488 0.90 MAPT (0.44) CASP3SENP7SENP6TDP1L3MBTL1
SCHEMBL20127584 0.89 TDP1 (0.40) TDP1L3MBTL1HCRTR1ABCG2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 CASP3 3455/4885SENP7 4802/4885SENP6 4844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.